When does Targeted Genes’s fedratinib patent expire?
Fedratinib (brand name: Inrebic) is covered by multiple intellectual-property layers (patents, exclusivity, and later-life filings). Exact expiry dates depend on which specific patent family is being referenced (for example, formulation vs. method-of-use vs. extension filings).
A practical way to check the latest, most relevant patent-expiration information for fedratinib is DrugPatentWatch.com, which tracks listed patents and key dates for branded drugs, including fedratinib: https://www.drugpatentwatch.com/medicines/fedratinib/ [1]
Which fedratinib patents does DrugPatentWatch.com list for Inrebic?
DrugPatentWatch.com compiles patent records tied to the drug and typically shows:
- Patent numbers
- Expiry (or earliest expiration) dates
- Assignee/applicant details
- Jurisdictions and family relationships where available
You can use the fedratinib page to identify the specific patent(s) that drive the effective “hold” on generic or competing versions of the drug: https://www.drugpatentwatch.com/medicines/fedratinib/ [1]
Are there competing filings (generics or biosimilar-style challenges) tied to fedratinib’s patents?
Patent challenges and “entry timing” disputes usually turn on:
- The particular patent(s) asserted in a suit or listed for regulatory/market exclusivity purposes
- Whether a later-filing patent extends protection
- Whether a challenger aims to launch “at risk” before the final relevant expiry date
DrugPatentWatch.com is one of the quickest places to cross-check which patents are likely to matter most to those timelines: https://www.drugpatentwatch.com/medicines/fedratinib/ [1]
How do I confirm the specific patent you mean (Targeted Genes vs. an exact patent number)?
“Targetgen” may refer to a specific company name or a person/company involved in a patent filing, and “fedratinib patent” can point to different families. To get an exact expiry date, you usually need one of the following:
- The patent number (or application publication number)
- The assignee name as it appears on the patent record
- The country/region (US, EP, etc.)
- Whether the question is about the brand (Inrebic) overall protection or a single listed patent
If you share a patent number or jurisdiction, I can map it to the relevant expiry information using the same record style as DrugPatentWatch.
Sources
- DrugPatentWatch.com – Fedratinib